{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:40:54Z","timestamp":1793947254305,"version":"4.8.0"},"reference-count":17,"publisher":"SAGE Publications","issue":"5","license":[{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/501100009780","name":"region sk\u00e5ne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003252","name":"lunds universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003252","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Diabetes Sci Technol"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>The gold standard for monitoring long-term glucose levels in patients with diabetes mellitus is glycated hemoglobin (HbA1c). In conditions where the erythrocyte half-life is decreased, for example, in long-term kidney diseases and hemoglobinopathies, HbA1C may underestimate the long-term glucose exposure. Therefore, in these patient groups, other methods to monitor long-term glucose have been suggested, including glycated serum protein (GSP). To further optimize the method, a correction against total serum albumin has been proposed, defined as a percentage of glycated albumin (%GA). The aim of this study was to investigate the correlation between HbA1c, GSP, and %GA\u2014a strong correlation to HbA1c would strengthen the potential usefulness of GSP and %GA as alternative methods to monitor glucose exposure in certain patient populations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>In this study, randomly collected human samples (n = 271), with different levels of HbA1c were analyzed for GSP and total serum albumin and a %GA was calculated. We also divided the samples into subgroups based on their HbA1c-result, age, and gender.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Both %GA and GSP were strongly correlated with HbA1c, where %GA displayed the strongest correlation (\n                      <jats:italic toggle=\"yes\">R<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      0.77 compared with\n                      <jats:italic toggle=\"yes\">R<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      0.66.). When dividing into subgroups based on HbA1c-results, statistically significant differences in %GA were observed between all the different subgroups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>In conclusion, the findings of this study strengthen the possibility of using GSP and %GA as possible alternatives or at least a supplement to HbA1c for monitoring long-term glucose exposure. Theoretically, particularly %GA could have the potential to supplement HbA1C in patients where the erythrocyte half-life is altered.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/19322968251384304","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:18:51Z","timestamp":1761056331000},"page":"1613-1618","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":3,"title":["Glycated Albumin Percentage is Correlated With HbA1c: Theoretic Marker in Patients With Altered Erythrocyte Turnover"],"prefix":"10.1177","volume":"20","author":[{"given":"Mats","family":"G\u00e5fvels","sequence":"first","affiliation":[{"name":"Department of Medical Sciences, Uppsala University Hospital, Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Sw\u00e4rd","sequence":"additional","affiliation":[{"name":"Clinical and Molecular Osteoporosis Research Unit, Departments of Orthopedics and Clinical Sciences, Sk\u00e5ne University Hospital, Lund University, Malm\u00f6, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Xu","sequence":"additional","affiliation":[{"name":"Division of Clinical Chemistry and Pharmacology, Department of Laboratory Medicine, Lund University, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9670-494X","authenticated-orcid":false,"given":"Joel","family":"Svensson","sequence":"additional","affiliation":[{"name":"Division of Clinical Chemistry and Pharmacology, Department of Laboratory Medicine, Lund University, Lund, Sweden"},{"name":"Unilabs Laboratory Medicine, Skaraborg Hospital, Sk\u00f6vde, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,10,21]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0038877"},{"key":"e_1_3_3_3_2","article-title":"Tests of glycemia in diabetes","volume":"23","author":"American Diabetes A","year":"2000","unstructured":"American Diabetes A. Tests of glycemia in diabetes. Diabetes Care. 2000;23 suppl 1:S80-S82.","journal-title":"Diabetes Care"},{"issue":"49","key":"e_1_3_3_4_2","first-page":"2246","article-title":"[HbA1c will complement other methods in the diagnosis of diabetes. Coordinated introduction in Sweden in January 2014]","volume":"110","author":"Lilja M","year":"2013","unstructured":"Lilja M, Jansson S, Alvarsson M, et al. [HbA1c will complement other methods in the diagnosis of diabetes. Coordinated introduction in Sweden in January 2014]. Lakartidningen. 2013;110(49-50):2246-2248.","journal-title":"Lakartidningen"},{"issue":"4","key":"e_1_3_3_5_2","first-page":"197","article-title":"International expert committee report on the role of the A1c assay in the diagnosis of diabetes: diabetes care 2009; 32(7) 1327-1334","volume":"30","author":"Gillett MJ.","year":"2009","unstructured":"Gillett MJ. International expert committee report on the role of the A1c assay in the diagnosis of diabetes: diabetes care 2009; 32(7) 1327-1334. Clin Biochem Rev. 2009;30(4):197-200.","journal-title":"Clin Biochem Rev"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1515\/CCLM.2010.144"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/47.2.153"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20192300"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2006070772"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-010-0242-0"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-024-01599-2"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2015.01.011"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1039\/c3ay40165k"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1177\/1932296814567894"},{"key":"e_1_3_3_15_2","unstructured":"Roche Diagnostics. Albumin Gen.2 product insert. https:\/\/diagnostics.roche.com\/global\/en\/products\/lab\/alb2-cps-000014.html. Accessed September 25 2025."},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1177\/193229680900300307"},{"issue":"10","key":"e_1_3_3_17_2","first-page":"200213","article-title":"Analytical performance of two enzymatic methods for glycated albumin","volume":"66","author":"Yun SG","year":"2020","unstructured":"Yun SG, Kim SW, Shin GH, et al. Analytical performance of two enzymatic methods for glycated albumin. Clin Lab. 2020;66(10):200213.","journal-title":"Clin Lab"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(14)70003-8"}],"container-title":["Journal of Diabetes Science and Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/19322968251384304","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/19322968251384304","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/19322968251384304","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T07:03:05Z","timestamp":1788246185000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/19322968251384304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.1177\/19322968251384304"],"URL":"https:\/\/doi.org\/10.1177\/19322968251384304","relation":{},"ISSN":["1932-2968","1932-2968"],"issn-type":[{"value":"1932-2968","type":"print"},{"value":"1932-2968","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,21]]}}}